BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Fuji
McKinsey
US Department of Justice
Novartis
Johnson and Johnson
AstraZeneca
Daiichi Sankyo
McKesson
Boehringer Ingelheim

Generated: January 23, 2018

DrugPatentWatch Database Preview

CEFTIN Drug Profile

« Back to Dashboard

When do Ceftin patents expire, and what generic alternatives are available?

Ceftin is a drug marketed by Glaxosmithkline and is included in two NDAs.

The generic ingredient in CEFTIN is cefuroxime axetil. There are sixty-one drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the cefuroxime axetil profile page.
Drug patent expirations by year for CEFTIN
Pharmacology for CEFTIN

US Patents and Regulatory Information for CEFTIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline CEFTIN cefuroxime axetil FOR SUSPENSION;ORAL 050672-001 Jun 30, 1994 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glaxosmithkline CEFTIN cefuroxime axetil TABLET;ORAL 050605-002 Dec 28, 1987 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glaxosmithkline CEFTIN cefuroxime axetil FOR SUSPENSION;ORAL 050672-002 Apr 29, 1997 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glaxosmithkline CEFTIN cefuroxime axetil TABLET;ORAL 050605-001 Dec 28, 1987 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glaxosmithkline CEFTIN cefuroxime axetil TABLET;ORAL 050605-003 Dec 28, 1987 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Harvard Business School
Queensland Health
Cantor Fitzgerald
McKinsey
Express Scripts
UBS
US Army
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot